Researchers at Dublin City University & Beaumont Hospital in race to identify brain tumour patients that respond to new
Novel patient-relevant brain tumour cancer research study being carried out in Dublin, Ireland looking at patient samples at the molecular level to identify which specific patients respond to a new group of drugs called Tyrosine Kinase Inhibitors.
Discuss Bury
NDW PR Center is a Web 2.0 News release and distribution service
